Qiagen INC:1110297 [14-007127]
Ended Awarded Last action
- Contract number
- HHSN26100013
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,060
Award facts
- Contract value 100% obligated
- $4,060.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$190 | |
| Original award | $4,250 |
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Cancer Institute to Qiagen, LLC for a ceiling value of $4,060.08. The award was made on December 7, 2013, with an ultimate completion date of December 31, 2013. Qiagen, LLC, a foreign-owned manufacturer headquartered in Germantown, Maryland, specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract was awarded under a firm fixed price arrangement with no set-aside designation, indicating open competition in the federal marketplace. The place of performance is located in Potomac, Maryland.
As a child entity of the Netherlands-based parent company Qiagen N.V., Qiagen, LLC provides critical molecular diagnostics products and services across multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs. This BPA call falls under Qiagen's broader portfolio of federal contracts, which typically involve procurement of reagents, consumables, diagnostic testing kits, laboratory equipment such as QIAsymphony and QIAcube instruments, software licenses, and maintenance services. The National Cancer Institute's investment through this BPA call supports the company's capacity to deliver specialized molecular diagnostics capabilities in support of the Institute's research and clinical programs.
Quick answers
Who was awarded contract HHSN26100013?
HHSN26100013 was awarded to Qiagen, LLC by National Cancer Institute (National Institutes of Health) on December 7, 2013.
How much is contract HHSN26100013 worth?
The government has obligated $4,060 on HHSN26100013.
Is contract HHSN26100013 an order under another contract?
Yes. HHSN26100013 is a BPA call under HHSN263200100054095B, a blanket purchase agreement.
Was contract HHSN26100013 competed?
The extent of competition for HHSN26100013 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award